Mason Archival Repository Service

Effect of Psychedelic (LSD and Psilocybin) Use in Treating Mental Disorders like Major Depressive Disorder (MDD)

Show simple item record

dc.contributor.author Kahn, Zehra
dc.date.accessioned 2022-05-16T18:06:00Z
dc.date.available 2022-05-16T18:06:00Z
dc.date.issued 2022-05
dc.identifier.uri http://hdl.handle.net/1920/12870
dc.description.abstract Major Depressive Disorder (MDD) is a widespread problem throughout the United States with no shortage of treatments. Psilocybin, a serotonin agonist, is treatment for MDD that showed great potential but wasn’t explored much until recently. Psilocybin, when administered in micro doses along with therapy, showed great curative potential for MDD, ameliorating symptoms for long periods of time. Psilocybin has also shown to work quickly and was not addictive to the patients. This review looks at studies testing psilocybin as a treatment for MDD. en_US
dc.rights Attribution-NonCommercial-NoDerivs 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/us/ *
dc.subject major depressive disorder en_US
dc.subject LSD en_US
dc.subject psychedelics en_US
dc.title Effect of Psychedelic (LSD and Psilocybin) Use in Treating Mental Disorders like Major Depressive Disorder (MDD) en_US
dc.type Article en_US


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States

Search MARS


Browse

My Account

Statistics